184 related articles for article (PubMed ID: 30036856)
1. Effects of injectable trace minerals administered concurrently with a modified live virus vaccine on long-term protection against bovine viral diarrhea virus acute infection in dairy calves.
Bittar JHJ; Hoyos-Jaramillo A; Hurley DJ; Woolums AR; Havenga LJ; Lourenço JM; Barnett G; Gomes V; Saliki JT; Harmon DD; Palomares RA
Res Vet Sci; 2018 Aug; 119():250-258. PubMed ID: 30036856
[TBL] [Abstract][Full Text] [Related]
2. Immune response and onset of protection from Bovine viral diarrhea virus 2 infection induced by modified-live virus vaccination concurrent with injectable trace minerals administration in newly received beef calves.
Bittar JHJ; Palomares RA; Hurley DJ; Hoyos-Jaramillo A; Rodriguez A; Stoskute A; Hamrick B; Norton N; Adkins M; Saliki JT; Sanchez S; Lauber K
Vet Immunol Immunopathol; 2020 Jul; 225():110055. PubMed ID: 32438245
[TBL] [Abstract][Full Text] [Related]
3. Clinical status and endoscopy of the upper respiratory tract of dairy calves infected with Bovine viral diarrhea virus 2 and Bovine herpes virus 1 after vaccination and trace minerals injection.
Hoyos-Jaramillo A; Palomares RA; Bittar JH; Divers SJ; Chamorro MF; Berghaus R; Kirks SJ; Rush J; Edmondson M; Rodriguez A; Gonzalez-Altamiranda EA
Res Vet Sci; 2022 Dec; 152():582-595. PubMed ID: 36201905
[TBL] [Abstract][Full Text] [Related]
4. Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves.
Palomares RA; Hurley DJ; Bittar JH; Saliki JT; Woolums AR; Moliere F; Havenga LJ; Norton NA; Clifton SJ; Sigmund AB; Barber CE; Berger ML; Clark MJ; Fratto MA
Vet Immunol Immunopathol; 2016 Oct; 178():88-98. PubMed ID: 27496747
[TBL] [Abstract][Full Text] [Related]
5. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
[TBL] [Abstract][Full Text] [Related]
6. Characterization of protection from systemic infection and disease by use of a modified-live noncytopathic bovine viral diarrhea virus type 1 vaccine in experimentally infected calves.
Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Abdelmagid OY; Eskridge KM
Am J Vet Res; 2005 Oct; 66(10):1785-91. PubMed ID: 16273912
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the onset of protection induced by a modified-live virus vaccine in calves challenge inoculated with type 1b bovine viral diarrhea virus.
Palomares RA; Givens MD; Wright JC; Walz PH; Brock KV
Am J Vet Res; 2012 Apr; 73(4):567-74. PubMed ID: 22452506
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of multivalent, modified- live virus (MLV) vaccines administered to early weaned beef calves subsequently challenged with virulent Bovine viral diarrhea virus type 2.
Chamorro MF; Walz PH; Passler T; van Santen E; Gard J; Rodning SP; Riddell KP; Galik PK; Zhang Y
BMC Vet Res; 2015 Feb; 11():29. PubMed ID: 25880998
[TBL] [Abstract][Full Text] [Related]
9. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
[TBL] [Abstract][Full Text] [Related]
10. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection.
Kovács F; Magyar T; Rinehart C; Elbers K; Schlesinger K; Ohnesorge WC
Vet Microbiol; 2003 Oct; 96(2):117-31. PubMed ID: 14519330
[TBL] [Abstract][Full Text] [Related]
11. Effect of injectable trace minerals on the humoral immune response to multivalent vaccine administration in beef calves.
Arthington JD; Havenga LJ
J Anim Sci; 2012 Jun; 90(6):1966-71. PubMed ID: 22178855
[TBL] [Abstract][Full Text] [Related]
12. Transmission of bovine viral diarrhea virus 1b to susceptible and vaccinated calves by exposure to persistently infected calves.
Fulton RW; Briggs RE; Ridpath JF; Saliki JT; Confer AW; Payton ME; Duff GC; Step DL; Walker DA
Can J Vet Res; 2005 Jul; 69(3):161-9. PubMed ID: 16187545
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of shedding of bovine herpesvirus 1, bovine viral diarrhea virus 1, and bovine viral diarrhea virus 2 after vaccination of calves with a multivalent modified-live virus vaccine.
Kleiboeker SB; Lee SM; Jones CA; Estes DM
J Am Vet Med Assoc; 2003 May; 222(10):1399-403. PubMed ID: 12762386
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the stress-reducing effect of trace mineral injection in beef calves.
Megahed AA; Bittar JHJ; Palomares RA; Mercadante VRG; Dias NW
J Vet Intern Med; 2023; 37(3):1278-1285. PubMed ID: 37186325
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of four commercially available multivalent modified-live virus vaccines against clinical disease, viremia, and viral shedding in early-weaned beef calves exposed simultaneously to cattle persistently infected with bovine viral diarrhea virus and cattle acutely infected with bovine herpesvirus 1.
Chamorro MF; Walz PH; Passler T; Palomares R; Newcomer BW; Riddell KP; Gard J; Zhang Y; Galik P
Am J Vet Res; 2016 Jan; 77(1):88-97. PubMed ID: 26709942
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of protection against virulent bovine viral diarrhea virus type 2 in calves that had maternal antibodies and were vaccinated with a modified-live vaccine.
Zimmerman AD; Boots RE; Valli JL; Chase CC
J Am Vet Med Assoc; 2006 Jun; 228(11):1757-61. PubMed ID: 16740078
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with a modified-live bovine viral diarrhea virus (BVDV) type 1a vaccine completely protected calves against challenge with BVDV type 1b strains.
Xue W; Mattick D; Smith L; Umbaugh J; Trigo E
Vaccine; 2010 Dec; 29(1):70-6. PubMed ID: 21034829
[TBL] [Abstract][Full Text] [Related]
18. Fetal protection against bovine viral diarrhea virus types 1 and 2 after the use of a modified-live virus vaccine.
Xue W; Mattick D; Smith L; Maxwell J
Can J Vet Res; 2009 Oct; 73(4):292-7. PubMed ID: 20046631
[TBL] [Abstract][Full Text] [Related]
19. Response of calves persistently infected with noncytopathic bovine viral diarrhea virus (BVDV) subtype 1b after vaccination with heterologous BVDV strains in modified live virus vaccines and Mannheimia haemolytica bacterin-toxoid.
Fulton RW; Step DL; Ridpath JF; Saliki JT; Confer AW; Johnson BJ; Briggs RE; Hawley RV; Burge LJ; Payton ME
Vaccine; 2003 Jun; 21(21-22):2980-5. PubMed ID: 12798641
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of an inactivated Chinese bovine viral diarrhea virus 1a (BVDV 1a) vaccine cross protects from BVDV 1b infection in young calves.
Wang W; Shi X; Wu Y; Li X; Ji Y; Meng Q; Zhang S; Wu H
Vet Immunol Immunopathol; 2014 Aug; 160(3-4):288-92. PubMed ID: 24880701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
